Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Résultat de la recherche
2 recherche sur le mot-clé 'Psychotropic drugs'
Affiner la recherche Générer le flux rss de la recherche
Partager le résultat de cette recherche Faire une suggestion
Prevalence of Psychotropic Medicine Use in Australian Children with Autism Spectrum Disorder: A Drug Utilization Study Based on Children Enrolled in the Longitudinal Study of Australian Children / L. RASMUSSEN in Journal of Autism and Developmental Disorders, 49-1 (January 2019)
[article]
Titre : Prevalence of Psychotropic Medicine Use in Australian Children with Autism Spectrum Disorder: A Drug Utilization Study Based on Children Enrolled in the Longitudinal Study of Australian Children Type de document : Texte imprimé et/ou numérique Auteurs : L. RASMUSSEN, Auteur ; N. PRATT, Auteur ; E. ROUGHEAD, Auteur ; A. MOFFAT, Auteur Article en page(s) : p.227-235 Langues : Anglais (eng) Mots-clés : Australia Autism Autism spectrum disorder Drug utilization Psychotropic drugs Index. décimale : PER Périodiques Résumé : Based on data from the Longitudinal Study of Australian Children linked with pharmacy dispensing data from the Australian Government's Pharmaceutical Benefits Scheme, we calculated the 1-year prevalence of psychotropic medicine supply in children and adolescents with Autism Spectrum Disorder (ASD) as reported by parents in 2014. The majority of children and adolescents with ASD in Australia were not treated with psychotropic medicine. One-third had claims for at least one psychotropic medication, most commonly medications for attention-deficit/hyperactivity disorder (ADHD), and antidepressants. Antipsychotics were supplied to less than one in twenty children and approximately one in ten adolescents. In line with findings from North America, psychotropic medicine was more often supplied to children and adolescents with ASD and comorbid ADHD. En ligne : http://dx.doi.org/10.1007/s10803-018-3718-3 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=377
in Journal of Autism and Developmental Disorders > 49-1 (January 2019) . - p.227-235[article] Prevalence of Psychotropic Medicine Use in Australian Children with Autism Spectrum Disorder: A Drug Utilization Study Based on Children Enrolled in the Longitudinal Study of Australian Children [Texte imprimé et/ou numérique] / L. RASMUSSEN, Auteur ; N. PRATT, Auteur ; E. ROUGHEAD, Auteur ; A. MOFFAT, Auteur . - p.227-235.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 49-1 (January 2019) . - p.227-235
Mots-clés : Australia Autism Autism spectrum disorder Drug utilization Psychotropic drugs Index. décimale : PER Périodiques Résumé : Based on data from the Longitudinal Study of Australian Children linked with pharmacy dispensing data from the Australian Government's Pharmaceutical Benefits Scheme, we calculated the 1-year prevalence of psychotropic medicine supply in children and adolescents with Autism Spectrum Disorder (ASD) as reported by parents in 2014. The majority of children and adolescents with ASD in Australia were not treated with psychotropic medicine. One-third had claims for at least one psychotropic medication, most commonly medications for attention-deficit/hyperactivity disorder (ADHD), and antidepressants. Antipsychotics were supplied to less than one in twenty children and approximately one in ten adolescents. In line with findings from North America, psychotropic medicine was more often supplied to children and adolescents with ASD and comorbid ADHD. En ligne : http://dx.doi.org/10.1007/s10803-018-3718-3 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=377 Aggressive behavior problems in children with autism spectrum disorders: Prevalence and correlates in a large clinical sample / Alison PRESMANES HILL in Research in Autism Spectrum Disorders, 8-9 (September 2014)
[article]
Titre : Aggressive behavior problems in children with autism spectrum disorders: Prevalence and correlates in a large clinical sample Type de document : Texte imprimé et/ou numérique Auteurs : Alison PRESMANES HILL, Auteur ; Katharine E. ZUCKERMAN, Auteur ; Arlene D. HAGEN, Auteur ; Daniel J. KRIZ, Auteur ; Susanne W. DUVALL, Auteur ; Jan P. H. VAN SANTEN, Auteur ; Joel NIGG, Auteur ; Damien A. FAIR, Auteur ; Eric FOMBONNE, Auteur Article en page(s) : p.1121-1133 Langues : Anglais (eng) Mots-clés : Autism spectrum disorders Psychotropic drugs Aggression Sleep Internalizing problems Attention problems Index. décimale : PER Périodiques Résumé : Abstract Aggressive behavior problems (ABP) are frequent yet poorly understood in children with autism spectrum disorders (ASD) and are likely to co-vary significantly with comorbid problems. We examined the prevalence and sociodemographic correlates of ABP in a clinical sample of children with ASD (N = 400; 2–16.9 years). We also investigated whether children with ABP experience more intensive medical interventions, greater impairments in behavioral functioning, and more severe comorbid problems than children with ASD who do not have ABP. One in four children with ASD had Child Behavior Checklist scores on the Aggressive Behavior scale in the clinical range (T-scores ? 70). Sociodemographic factors (age, gender, parent education, race, ethnicity) were unrelated to ABP status. The presence of ABP was significantly associated with increased use of psychotropic drugs and melatonin, lower cognitive functioning, lower ASD severity, and greater comorbid sleep, internalizing, and attention problems. In multivariate models, sleep, internalizing, and attention problems were most strongly associated with ABP. These comorbid problems may hold promise as targets for treatment to decrease aggressive behavior and proactively identify high-risk profiles for prevention. En ligne : http://dx.doi.org/10.1016/j.rasd.2014.05.006 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=238
in Research in Autism Spectrum Disorders > 8-9 (September 2014) . - p.1121-1133[article] Aggressive behavior problems in children with autism spectrum disorders: Prevalence and correlates in a large clinical sample [Texte imprimé et/ou numérique] / Alison PRESMANES HILL, Auteur ; Katharine E. ZUCKERMAN, Auteur ; Arlene D. HAGEN, Auteur ; Daniel J. KRIZ, Auteur ; Susanne W. DUVALL, Auteur ; Jan P. H. VAN SANTEN, Auteur ; Joel NIGG, Auteur ; Damien A. FAIR, Auteur ; Eric FOMBONNE, Auteur . - p.1121-1133.
Langues : Anglais (eng)
in Research in Autism Spectrum Disorders > 8-9 (September 2014) . - p.1121-1133
Mots-clés : Autism spectrum disorders Psychotropic drugs Aggression Sleep Internalizing problems Attention problems Index. décimale : PER Périodiques Résumé : Abstract Aggressive behavior problems (ABP) are frequent yet poorly understood in children with autism spectrum disorders (ASD) and are likely to co-vary significantly with comorbid problems. We examined the prevalence and sociodemographic correlates of ABP in a clinical sample of children with ASD (N = 400; 2–16.9 years). We also investigated whether children with ABP experience more intensive medical interventions, greater impairments in behavioral functioning, and more severe comorbid problems than children with ASD who do not have ABP. One in four children with ASD had Child Behavior Checklist scores on the Aggressive Behavior scale in the clinical range (T-scores ? 70). Sociodemographic factors (age, gender, parent education, race, ethnicity) were unrelated to ABP status. The presence of ABP was significantly associated with increased use of psychotropic drugs and melatonin, lower cognitive functioning, lower ASD severity, and greater comorbid sleep, internalizing, and attention problems. In multivariate models, sleep, internalizing, and attention problems were most strongly associated with ABP. These comorbid problems may hold promise as targets for treatment to decrease aggressive behavior and proactively identify high-risk profiles for prevention. En ligne : http://dx.doi.org/10.1016/j.rasd.2014.05.006 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=238